Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox.
Clinical trial NCT02159040 · TERMINATED
Trial details
- NCT number
- NCT02159040
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-11
- Primary completion
- 2015-06-26
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.